Upsher-Smith To Pay £223M For UK Drug Co. Proximagen – site.law360.com

June 13, 2012 Posted By: Leave a comment
Law360, New York (June 13, 2012, 1:40 PM ET) -- Pharmaceuticals manufacturer Upsher-Smith Laboratories Inc. will shore up its product pipeline with the £223 million ($346.7 million) purchase of British biotech company Proximagen Group PLC, a neuroscience ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>